2001
DOI: 10.1006/phrs.2001.0811
|View full text |Cite
|
Sign up to set email alerts
|

The influence of divalent cations on the analgesic effect of opioid and non-opioid drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
6
0
1

Year Published

2007
2007
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 37 publications
1
6
0
1
Order By: Relevance
“…Aspirin and levetiracetam-aspirin combination produced high antinociceptive efficacy in diabetic mice in both tests compared to weak efficacy (tail-flick test), and no effect (von Frey test) in nondiabetic mice. The general lack of antinociception of individually applied drugs in non-diabetic mice is in line with previous studies which showed no effect of levetiracetam [6,7], ibuprofen [36], aspirin [37,38] and paracetamol [39] in healthy mice/rats in thermal/mechanical pain tests. Therefore, we could hypothesize that the determined antinociceptive effects of levetiracetam, analgesics and levetiracetam-analgesic combinations in diabetic mice are dependent on neuropathic changes caused by diabetes.…”
Section: Discussionsupporting
confidence: 88%
“…Aspirin and levetiracetam-aspirin combination produced high antinociceptive efficacy in diabetic mice in both tests compared to weak efficacy (tail-flick test), and no effect (von Frey test) in nondiabetic mice. The general lack of antinociception of individually applied drugs in non-diabetic mice is in line with previous studies which showed no effect of levetiracetam [6,7], ibuprofen [36], aspirin [37,38] and paracetamol [39] in healthy mice/rats in thermal/mechanical pain tests. Therefore, we could hypothesize that the determined antinociceptive effects of levetiracetam, analgesics and levetiracetam-analgesic combinations in diabetic mice are dependent on neuropathic changes caused by diabetes.…”
Section: Discussionsupporting
confidence: 88%
“…Literature data show that MS at a dose of 2.5 mg/kg (0.5 mg of elementary magnesium, i.p.) had no analgesic effect (Assi et al, 2001) and magnesium oxide at doses of 5 and 10 mg/kg (3.02 and 6.03 mg of elementary magnesium, i.p.) had analgesic effect (Jahangiri et al, 2013) in acetic acid-induced writhing test in mice.…”
Section: Discussionmentioning
confidence: 95%
“…Additionally, magnesium acts as an antagonist at the glutamate subtype of NMDA receptors and blocks NMDA-induced currents in a voltage-dependent manner by blocking the receptor channel effects (Fawcett et al, 1999). Several lines of evidence indicate that magnesium enhances the analgesic effects of opioids, general, and local anesthetics in different animal models of pain (Assi, 2001;Liu et al, 2001;Nechifor, 2011). As a sole drug, magnesium demonstrated analgesic efficacy against neuropathic pain (Begon et al, 2000;Rondón et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…In the tail-flick 21 or hot plate 22 assays in mice, neither 5a (doses up to 3010 lmol/kg) nor APAP (doses up to 6620 lmol/kg) was effective (data not shown), a finding that is consistent with previous studies that have demonstrated no or weak analgesic activity of APAP in these assay. 23 Moreover, neither 5a nor APAP was found to possess anti-inflammatory properties in a model of carrageenan-induced paw edema 24 (Fig. 4).…”
Section: Resultsmentioning
confidence: 98%
“…Carrageenan-induced paw edema. 24 Under halothane anesthesia male CD-1 mice were injected with lambda-carrageenan (50 lL, 1% in saline; Sigma) via the plantar surface of one hind paw 30 min after drug administration. Inflammation (paw volume: model 520 paw volume meter; IITC Life Sciences, Inc., Woodland Hills, CA.)…”
Section: 34mentioning
confidence: 99%